AstraZeneca (AZNL)

12,014.00p
   
  • Change Today:
    -0.82p
  • 52 Week High: 13,250.00p
  • 52 Week Low: 9,642.00p
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 177,040
  • Market Cap: £151,876m

Financial Analysis

Select chart: EPS | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
30-Jun-25 Interim 28,045.00 6,529.00 346.00¢ 103.00¢

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 26,617.00 3,916.00 244.00¢ 40.7 0.3 +137% 280.00¢ 2.8%
31-Dec-21 37,417.00 (265.00) 8.00¢ 1,463.4 n/a -97% 287.00¢ 2.5%
31-Dec-22 44,351.00 2,501.00 212.00¢ 71.7 0.0 +2,550% 290.00¢ 1.9%
31-Dec-23 45,811.00 6,899.00 726.00¢ 19.7 0.1 +242% 290.00¢ 2.0%
31-Dec-24 54,073.00 8,691.00 821.00¢ 17.2 1.3 +13% 310.00¢ 2.2%

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 58,056.48 18,132.64 668.99p 17.9 1.7 +10% 238.81p 0.0%
31-Dec-26 61,716.07 20,560.16 760.13p 15.8 1.2 +14% 251.28p 0.0%
31-Dec-27 65,519.76 23,063.25 841.44p 14.2 1.3 +11% 262.36p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 41.10 15.94 320.56 0.06

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,014.00p
Change Today -0.82p
% Change -0.68 %
52 Week High 13,250.00p
52 Week Low 9,642.00p
Volume 177,040
Shares Issued 1,264.16m
Market Cap £151,876m

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 4
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 22-Aug-2025

Time Volume / Share Price
16:29 45 @ 11,978.00p
16:29 44 @ 11,978.00p
16:29 70 @ 11,979.00p
16:29 28 @ 11,979.00p
16:29 3 @ 11,979.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page